BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38070154)

  • 1. MMCL-CDR: enhancing cancer drug response prediction with multi-omics and morphology images contrastive representation learning.
    Li Y; Guo Z; Gao X; Wang G
    Bioinformatics; 2023 Dec; 39(12):. PubMed ID: 38070154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GraphCDR: a graph neural network method with contrastive learning for cancer drug response prediction.
    Liu X; Song C; Huang F; Fu H; Xiao W; Zhang W
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34727569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prediction of drug sensitivity by multi-omics fusion reveals the heterogeneity of drug response in pan-cancer.
    Wang C; Zhang M; Zhao J; Li B; Xiao X; Zhang Y
    Comput Biol Med; 2023 Sep; 163():107220. PubMed ID: 37406589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAMP: response-aware multi-task learning with contrastive regularization for cancer drug response prediction.
    Lee K; Cho D; Jang J; Choi K; Jeong HO; Seo J; Jeong WK; Lee S
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36460623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of drug response in multilayer networks based on fusion of multiomics data.
    Yu L; Zhou D; Gao L; Zha Y
    Methods; 2021 Aug; 192():85-92. PubMed ID: 32798653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DELFOS-drug efficacy leveraging forked and specialized networks-benchmarking scRNA-seq data in multi-omics-based prediction of cancer sensitivity.
    Piochi LF; Preto AJ; Moreira IS
    Bioinformatics; 2023 Nov; 39(11):. PubMed ID: 37862234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep learning and multi-omics approach to predict drug responses in cancer.
    Wang C; Lye X; Kaalia R; Kumar P; Rajapakse JC
    BMC Bioinformatics; 2022 Nov; 22(Suppl 10):632. PubMed ID: 36443676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrastively generative self-expression model for single-cell and spatial multimodal data.
    Zhang C; Yang Y; Tang S; Aihara K; Zhang C; Chen L
    Brief Bioinform; 2023 Sep; 24(5):. PubMed ID: 37507114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RedCDR: Dual Relation Distillation for Cancer Drug Response Prediction.
    Xu M; Zhu Z; Zhao Y; He K; Huang Q; Zhao Y
    IEEE/ACM Trans Comput Biol Bioinform; 2024 May; PP():. PubMed ID: 38776197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MODILM: towards better complex diseases classification using a novel multi-omics data integration learning model.
    Zhong Y; Peng Y; Lin Y; Chen D; Zhang H; Zheng W; Chen Y; Wu C
    BMC Med Inform Decis Mak; 2023 May; 23(1):82. PubMed ID: 37147619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOLI: multi-omics late integration with deep neural networks for drug response prediction.
    Sharifi-Noghabi H; Zolotareva O; Collins CC; Ester M
    Bioinformatics; 2019 Jul; 35(14):i501-i509. PubMed ID: 31510700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancancer survival prediction using a deep learning architecture with multimodal representation and integration.
    Fan Z; Jiang Z; Liang H; Han C
    Bioinform Adv; 2023; 3(1):vbad006. PubMed ID: 36845202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DROEG: a method for cancer drug response prediction based on omics and essential genes integration.
    Wu P; Sun R; Fahira A; Chen Y; Jiangzhou H; Wang K; Yang Q; Dai Y; Pan D; Shi Y; Wang Z
    Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36715269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-way relation-enhanced hypergraph representation learning for anti-cancer drug synergy prediction.
    Liu X; Song C; Liu S; Li M; Zhou X; Zhang W
    Bioinformatics; 2022 Oct; 38(20):4782-4789. PubMed ID: 36000898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions.
    Peng W; Liu H; Dai W; Yu N; Wang J
    Bioinformatics; 2022 Sep; 38(19):4546-4553. PubMed ID: 35997568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DeepCDR: a hybrid graph convolutional network for predicting cancer drug response.
    Liu Q; Hu Z; Jiang R; Zhou M
    Bioinformatics; 2020 Dec; 36(Suppl_2):i911-i918. PubMed ID: 33381841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAMR: cross-aligned multimodal representation learning for cancer survival prediction.
    Wu X; Shi Y; Wang M; Li A
    Bioinformatics; 2023 Jan; 39(1):. PubMed ID: 36637188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data.
    Park S; Soh J; Lee H
    BMC Bioinformatics; 2021 May; 22(1):269. PubMed ID: 34034645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
    Wang Y; Yang Y; Chen S; Wang J
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal Sentiment Analysis Representations Learning via Contrastive Learning with Condense Attention Fusion.
    Wang H; Li X; Ren Z; Wang M; Ma C
    Sensors (Basel); 2023 Mar; 23(5):. PubMed ID: 36904883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.